Kane Biotech Inc. (KNE.V)
TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
As of 09:37AM EDT. Market open.
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 16.56M |
| Enterprise value | 24.93M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 97.28 |
| Price/book (mrq) | 107.98 |
| Enterprise value/revenue | 150.57 |
| Enterprise value/EBITDA | -6.17 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 30.00% |
| S&P500 52-week change 3 | 24.78% |
| 52-week high 3 | 0.1700 |
| 52-week low 3 | 0.0500 |
| 50-day moving average 3 | 0.1302 |
| 200-day moving average 3 | 0.0928 |
Share statistics
| Avg vol (3-month) 3 | 173.31k |
| Avg vol (10-day) 3 | 130.13k |
| Shares outstanding 5 | 132.51M |
| Implied shares outstanding 6 | 152.13M |
| Float 8 | 96.08M |
| % held by insiders 1 | 34.93% |
| % held by institutions 1 | 0.00% |
| Shares short (15 May 2024) 4 | 969 |
| Short ratio (15 May 2024) 4 | 0 |
| Short % of float (15 May 2024) 4 | N/A |
| Short % of shares outstanding (15 May 2024) 4 | 0.00% |
| Shares short (prior month 15 Apr 2024) 4 | 17.63k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 13 Mar 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 13 Mar 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -2,289.83% |
Management effectiveness
| Return on assets (ttm) | -40.64% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 165.59k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -92.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -3.55M |
| Net income avi to common (ttm) | -4.94M |
| Diluted EPS (ttm) | -0.0400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 826.7k |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | 9.2M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.31 |
| Book value per share (mrq) | -0.08 |
Cash flow statement
| Operating cash flow (ttm) | -3.25M |
| Levered free cash flow (ttm) | -551.78k |
© 2024 Yahoo. All rights reserved.